Dr. Clemens Auer
Special Commissioner for Health | Health and Social Affairs Ministry, Austrian Government
Dr. Auer currently holds the role as Special Commissioner for Health at the Health and Social Affairs Ministry in Austria. Since 2003 he has been involved in central functions in the Austrian government, contributing substantially to health reforms such as medicines reimbursement (Reimbursement Codex), the establishment and expansion of a new medicines approval agency in the AGES and the GesundheitÖsterreich-GmbH, reforms in the area of social health insurance, quality assurance systems, as well as e-Health.
Dr. Auer was elected in September 2018 to the Executive Board of the World Health Organization in Geneva for the period 2019-2022.
Since 2020, he has been a member of the European Commission's Negotiating Group, where he co-chairs the supply of vaccines for EU Member States. He also plays a central role in health care reforms in Austria and in the launch of the national vaccination campaign against COVID-19.
HPD Inspector | Compliance Department, Irish Health Products Regulatory Authority
Joanne Bergin is a Health Products Distribution inspector, working with the HPRA since 2015. Joanne originally qualified as a pharmacist from Trinity College Dublin and spent eight years working in community pharmacy. Prior to joining the HPRA, Joanne worked as an inspector with the Pharmaceutical Society of Ireland, the regulator of pharmacists and pharmacies in Ireland. Joanne completed a Masters Degree in Pharmaceutical Medicine from Trinity College Dublin in 2014. She has participated in a joint visit programme with The Pharmaceutical Inspection Co-operation Scheme (PIC/S) in 2018 and also presented at GIRP’s supply chain conference in 2020.
Managing Director | Kwizda Pharmahandel GmbH
In 2012, Thomas Brosch was appointed Managing Director of Kwizda Pharmahandel GmbH, the second pharmaceutical wholesaler in Austria. He has also been a board member of PHAGO (Austrian Association of Full-Line Pharmaceutical Wholesalers) since 2012 and of AMVO (Austrian Medicine Verification Organisation) since 2017. Before working in the pharmaceutical wholesale business Thomas Brosch was working as a Tax Adviser and Auditor (1992-1997) and was Finance Manager of Agip Austria and Agip Slovenija (1997-2006) and of Kwizda Group (2006-2012).
Senior GDP Inspector | Medicines and Healthcare Products Regulatory Agency
Peter Brown has been a Medicines Inspector since October 2015, and was appointed to the post of Senior Inspector in March 2019, following a long career in wholesale operations and quality management. His current portfolio encompasses leading inspections around intelligence led or suspected serious non-compliance management. This role includes supporting criminal investigations, and he has recently utilised this experience to update MHRA guidance around high risk areas of compliance, including bona fide qualification.
Head of manufacturing and quality compliance service | European Medicines Agency
Brendan Cuddy joined the European Medicines Agency in October 2002. He was Head of the Manufacturing and Quality Compliance Service at the Agency from 2014 – 2020.
Brendan is currently the Chairman of the Good Manufacturing and Distribution Practice Inspectors Working Group (GMDP IWG).
Brendan obtained his degree in Chemistry from University of Dublin, Trinity College in Ireland. He holds a Master’s degree from the National University of Ireland in Quality and Operations Management and a postgraduate diploma in Pharmaceutical Manufacturing Technology from University of Dublin, Trinity College which satisfies the educational requirements for Qualified Person.
Director Sales Healthcare Solutions | KNAPP AG
Matthias Dalkner was appointed KNAPP AG’s Sales Director for their Healthcare Business Unit in 2016. In his global role, he is responsible for the Account Management of KNAPP’s largest customer base, which is pharmaceutical wholesale, as well as the Business Development in all healthcare sectors. Having been with KNAPP for 18 years, he has not only gained profound knowledge of warehouse automation but also of the intricacies of the pharmaceutical supply chain. Matthias has a Master of Arts in Business from CAMPUS 02 University of Applied Sciences in Graz.
President | PGEU
Alain Delgutte is the President of PGEU, which represents community pharmacy in Europe, for the year 2021.
A practicing pharmacy owner in Nevers, Burgundy, Alain Delgutte sits on the National Council of the French Chamber of Pharmacists, the self-regulation body for the whole pharmacy profession in France, where he oversees matters pertaining to professional practice and European affairs.
Alain Delgutte previously chaired the national Council of Pharmacy Owners of the French Chamber from 2012 to 2019.
A member of the administrative and executive boards of the Pharmacist Pension Scheme Fund and a Lieutenant-Colonel in the Nevers firefighters, he holds a Pharmacy diploma, as well as a Master's degree in business management and orthopaedics qualifications.
Dr. Monica Dias
Principal Policy and Crisis Coordinating Officer | European Medicine Agency
Dr. Monica Dias joined the EMA in 2004, as of March 2013 she is the Principal Policy and Crisis Coordinating Officer. She coordinated Brexit preparedness activities including the impact of Brexit on the availability of medicines. Dr Dias is also coordinating at EMA the activities of the HMA/EMA Task Force on the availability of authorised medicines.
Dr. Dias coordinates activities in relation to shortages due the COVID-19 pandemic both for EMA and NCAs, including the setting up of the i-SPOC system and the EU Executive Steering Group on shortages. Dr. Dias Co-Chairs a Working Group tasked to develop a common framework for forecasting demand in the EU/EEA.
Member of Cool chain Association and Board Member of Tranfrigoroute France (LCCF) | Thermo King
He joined Thermo King in 1994 when we opened the HQ EMEA in Brussels, starting in marketing department being in charge of customer programs and events as well as coordination new unit launches. In 1995 became Field Service engineer in France and moved into commercial role in 1996. He has founded Thermo King Total Kare service contract company in 2000 which is now a company running more than 25000 units under corporate service contract, as well as coordinating and managing Global service agreements in rail and air segments. He then took over the International account department and moved this into Key-Strategic account department that he is still leading today. In between He has also been in charge of the Middle East Africa Region for 3 years. Grown and established service and distributors in West Africa. In 2013, he developed and brought to Market pharma solutions business and 2 years later, intermodal solutions.
Domain Architect Supply Chain | Novartis
Dan is the Industry Project Lead of PharmaLedger, a 3-year, 29-member, public-private project aimed at bringing the benefits of blockchain to patients. He is also the Supply Chain Architect at Novartis, responsible for IT standards and architecture direction as well as evaluation of emerging technologies. He has been at Novartis since 2002. He has 30 years of leadership and supply chain IT experience including the US Military, IT consulting, pharmaceutical manufacturing and global supply systems. He holds a B.S. from USMA and an eMBA from Duke Fuqua / Goethe University.
Senior Manager, Policy & Public Affairs & President Austrian Vaccine Manufacturer Association | Pfizer
Renée Gallo-Daniel has over 30 years’ experience within the pharmaceutical industry gained in different business roles at GSK and Pfizer. Since 2000 she is focused on vaccines topics. This very specific business including certain health care challenges within the pharmaceutical industry. Working within vaccines industry is strongly interconnected to the public health system, strong relationships with Stakeholder and connectivity across country level. Her business relationships are linked to different levels of medical, non-medical expert groups, health institutions, politics and as well to leaders within the Vaccine Manufacturer and pharmaceutical industry. She founded the Austrian Vaccine Manufacturers Association / ÖVIH in 2011 and currently leads the ÖVIH as President.
Director Regulatory Affairs | McKesson Canada
Claude Jolicoeur is Sr. Director, Regulatory Affairs, for McKesson Canada situated in the Montréal office. In this role, Claude is responsible for guidance in the compliance to all applicable regulations for the distribution of products, including, but not limited to, drugs, medical devices, controlled substances, precursors, Natural Health Products and recently with regulations around the legalization of Cannabis.
Claude Jolicoeur has 25 years of experience in distribution and holds a degree in Business Administration from McGill University in Montreal. Prior to joining McKesson Canada, Claude spent a number of years managing distribution centers for Bayer in Montréal and Johnson and Johnson in Markham, Ontario.
Executive Vice President, Government Affairs | Healthcare Distribution Alliance (HDA)
As HDA’s Executive Vice President of Government Affairs, Patrick Kelly oversees all of HDA’s government and political activities. Kelly sets strategic direction for the healthcare distribution industry’s advocacy agenda and leads the development of legislative and regulatory strategies to affect outcomes on priority issues.
Prior to joining the HDA in 2011, Kelly held government affairs positions with the Biotechnology Innovation Organization (BIO) and the Grocery Manufacturers Association (GMA). Kelly graduated from the University of Maryland with a degree in Government and Politics.
Director | McKesson Ireland
David has been involved in the pharmaceutical market for over 30 years.
His career within the sector commenced with the Bayer organisation where he held a number of sales and marketing roles.
Since 2002 he has operated within the supply chain sector and for the past 9 years he has been a Director of McKesson Ireland. His responsibilities include the management of United Drug Distributors, the Public Affairs activities of McKesson Ireland and leading the development of the McKesson EU Specialty Strategy incorporating the development of the Covid-19 vaccine supply chain.
Head of GMDP Inspections Department | Austrian Agency for Health and Food Safety (AGES)
"Andreas Krassnigg is head of GMDP inspection's Departement at the Austrian Federal Office for Safety in Health Care since 2006.
He is responsible for Manufacturer's and Wholesaler's Authorisations and related inspections and certificates. In his position he is Austria's delegate to the Inspector's Working Group at the European Medicines Agency and Austria's Committee Member of Officials at the Pharmaceutical Inspections Cooperation Scheme, where he is currently also Chair of the Subcommittee on Expert Circles.
After studying pharmacy at the University of Innsbruck, Tyrol, Andreas Krassnigg worked several years as a pharmacist. His core experience is in the field of herbal medicines, traditional pharmaceutical manufacturing, Good Distribution Practice and transportation."
Head of Manufacturer Solutions | McKesson Europe
Pedro Pereira is McKesson Europe Head of Manufacturer Solutions, with predominant focus on three businesses areas: specialty medicines, clinical trials, and own label supply chain distribution. Pedro began his career with McK subsidiary OCP Portugal more than 25 Years ago, gaining unparalleled experience in the Wholesale space, while also establishing himself as expert the Pre-Wholesale space after he led the operations of this division in McK Europe group. Previously as Head of Operations for McK Europe, Pedro had the opportunity to lead and support the wholesale operations across multiple countries and deploy more the 30 distributions centres across Europe & Latin America.
Business Development | RightHand Robotics
Manfred Preiss first specialized in the field of electronics and automation technology whilst studying at the Technical University of Nuremberg, Germany. Mr Preiss has since acquired 40 years of experience with picking systems, particularly within the pharmaceutical wholesale industry, having held, among others, the position of Vice President responsible for worldwide sales and product management at SSI Schäfer. He also founded his own company P+P Materialflusssysteme in 1980, which implemented picking solutions across Europe as well as in the US. Since 2019, Mr Preiss is responsible for business development at RightHand Robotics in Boston.
Head of Logistics Engineering | PHOENIX
Mr. Lutz Schütte is Head of Infrastructure. In his position he is responsible for all significant investment projects within the PHOENIX group.
Before starting his work at PHOENIX group he was more than 12 years manager in a worldwide operating consultancy. There he was responsible for numerous improvement and infrastructure projects, among other things in pharmaceutical, food, wholesale and retail industry.
Senior Manager Strategic Marketing Life Sciences | Sensitech
Olivier Simonnot has been working for Sensitech Inc., a unit of Carrier Corp., for thirteen years where he currently holds the position of Senior Manager Strategic Marketing Life Sciences. He previously held several positions in Marketing and Product Management in several international technology oriented companies.
He holds a Master of Science in Telecommunications from the French engineering school ESIGETEL and a Master in Business Administration from the Rotterdam School of Management. He has been an active member of several industry working groups, such as the French Cold Chain Association, the IATA Time & Temperature Task Force … and he has a large expertise in Global Regulatory Requirements regarding Cold Chain and Supply Chain Security.
Dr. Erik Van Asselt
Senior Specialist QA | MSD Netherlands
Dr. Erik van Asselt is working for more than 20 years in the pharmaceutical industry with strong experiences in Temperature Controlled Distribution, Data Integrity, Quality Risk Management, Lean Six Sigma, Packaging, and Stability Testing. He is a professional with a Doctor of Philosophy (Ph.D.) in Protein Crystallography from University of Groningen. Since 2009 he chairs the PDA Pharmaceutical Cold Chain Interest Group (PCCIG) - European Branch. In this role, he acts as frequent speaker at conferences and training courses, and writer of technical reports and articles about cold chain management, stability budget, last mile, and active/passive temperature-controlled transport.